To celebrate the anniversary of an arcane federal guideline is a rare event. For an agency to use that moment to invite reflection on modifying policies is even rarer. Last month, the U.S. National Institutes of Health (NIH) did just that, with a workshop that marked the 40th anniversary of its Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules. The meeting was an inspiring start for charting future oversight of nonclinical applications.
Citation
Maureen O’Leary, Kenneth A. Oye & Margaret Foster Riley, Revisit NIH biosafety guidelines, 357 Science 627 (2017).